miR-126-5p Targets SP1 to Inhibit the Progression of Parkinson's Disease.

Han, Yan-Ping; Liu, Zhi-Jun; Bao, Hong-Hui; Wang, Qiong; Su, Li-Li

Han, Yan-Ping; Liu, Zhi-Jun; Bao, Hong-Hui; Wang, Qiong; Su, Li-Li.

Afiliação

Han YP; Department of Neurology, Affiliated Hospital of Gansu University of Chinese Medicine, Lanzhou, China.
Liu ZJ; Department of Neurology, Affiliated Hospital of Gansu University of Chinese Medicine, Lanzhou, China.
Bao HH; Department of Neurology, Affiliated Hospital of Gansu University of Chinese Medicine, Lanzhou, China.
Wang Q; Department of Neurology, Affiliated Hospital of Gansu University of Chinese Medicine, Lanzhou, China.
Su LL; Department of Neurology, Affiliated Hospital of Gansu University of Chinese Medicine, Lanzhou, China.

Eur Neurol ; 85(3): 235-244, 2022.

Article em En | MEDLINE | ID: mdl-35108712

Assuntos

MicroRNAs; Doença de Parkinson; Fator de Transcrição Sp1; 1-Metil-4-fenilpiridínio/farmacologia; Apoptose/genética; Linhagem Celular Tumoral; Humanos; MicroRNAs/genética; Doença de Parkinson/patologia; Fator de Transcrição Sp1/genética

Palavras-chave

1-Methyl-4-phenylpyridinium; Parkinson' disease; Specific protein-1; miR-126-5p

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Fator de Transcrição Sp1 / MicroRNAs Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google